Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Andrew J. Greenfield currently holds 15,977 shares of ABIOMED INC (ABMD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Andrew J. Greenfield has been a net seller of ABMD stock. They have purchased $0 and sold $36.3M worth of shares.
Andrew J. Greenfield's most recent insider trade was on Dec 22, 2022, when they sold 23,484 shares at $0.00 per share.
Andrew J. Greenfield serves as Executive at ABIOMED INC (ABMD). They have executed 180 insider transactions totaling $36.3M over their tenure at the company.
Andrew J. Greenfield holds the position of Executive at ABIOMED INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Andrew J. Greenfield has shown a selling trading pattern, with $0 in total purchases and $36.3M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Andrew J. Greenfield was on Sep 24, 2018, when they sold $2.1M worth of ABMD shares. This transaction involved 5,000 shares at $420.00 per share.
Andrew J. Greenfield currently owns 15,977 shares of ABIOMED INC (ABMD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Andrew J. Greenfield's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Andrew J. Greenfield has 180 Form 4 filings on record as an insider at ABIOMED INC.
Set alerts for Andrew J. Greenfield and 40,000+ other insiders.